Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5111875

Cc1cccc(-c2ccc(F)cc2)c1NC(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
CHIT1 Q13231 1/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 1/20 0.40
EPHX2 P34913 1/20 0.39
PDCD1 Q15116 2/20 0.39
CD274 Q9NZQ7 2/20 0.39
CHRNA7 P36544 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
NTRK1 P04629 1/20 0.38
S1PR2 O95136 1/20 0.38
S1PR4 O95977 1/20 0.38
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3907243 0.93 KDM4E (0.51) KDM4ELMNASMN1; SMN2SLC6A4SLC6A3
Trifluoroacetic Acid SCHEMBL5112469 0.90 CHIT1 (0.41) CHIT1LMNASMN1; SMN2HTTNPSR1
Trifluoroacetic Acid SCHEMBL5107141 0.86 HTT (0.41) KDM4ECHIT1LMNASMN1; SMN2HTT
Trifluoroacetic Acid SCHEMBL5106740 0.85 CHRNA7 (0.42) KDM4ECHIT1LMNASMN1; SMN2HTT
Trifluoroacetic Acid SCHEMBL5103332 0.82 CHRNA7 (0.47) LMNASMN1; SMN2HTTNPSR1CHRNA7
Trifluoroacetic Acid SCHEMBL5100344 0.82 S1PR4 (0.46) CHIT1LMNASMN1; SMN2HTTNPSR1
Trifluoroacetic Acid SCHEMBL5111906 0.82 RAB9A (0.41) KDM4ECHIT1LMNASMN1; SMN2HTT
SCHEMBL5111878 0.82 SLC6A4 (0.41) KDM4ELMNASMN1; SMN2SLC6A4SLC6A3
Trifluoroacetic Acid SCHEMBL5106657 0.80 S1PR4 (0.47) CHIT1S1PR2S1PR4PDK1PDK2
SCHEMBL15627214 0.78 LMNA (0.47) KDM4ELMNASMN1; SMN2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 KDM4E 3835/4885CHIT1 3534/4885LMNA 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.